Murray, L. A., Zhang, H., Oak, S. R., Coelho, A. L., Herath, A., Flaherty, K. R., . . . Hogaboam, C. M. (2014). Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model. American Thoracic Society.
シカゴスタイル引用形Murray, Lynne A., et al. Targeting Interleukin-13 With Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model. American Thoracic Society, 2014.
MLA引用形式Murray, Lynne A., et al. Targeting Interleukin-13 With Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model. American Thoracic Society, 2014.
警告: この引用は必ずしも正確ではありません.